<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-04-07T02:08:20Z</responseDate>
  <request identifier="oai:pub.unibl.org:24880" metadataPrefix="oai_dcterms" verb="GetRecord">https://pub.unibl.org/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pub.unibl.org:24880</identifier>
        <datestamp>2026-01-24T04:43:30Z</datestamp>
      </header>
      <metadata>
        <oai_dcterms:dcterms xmlns:oai_dcterms="http://www.openarchives.org/OAI/2.0/oai_dcterms/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dcterms/ http://www.openarchives.org/OAI/2.0/oai_dcterms.xsd">
          <dcterms:title>EFFICACY AND SAFETY OF OMBITASVIR/PARITAPREVIR/RITONAVIR ± DASABUVIR REGIMEN IN PATIENTS WITH SEVERE RENAL IMPAIRMENT WITH HCV GENOTYPE 1B INFECTION – CASE REPORT</dcterms:title>
          <dcterms:creator xsi:type="dcterms:URI" title="Антонија Верхаз">https://www.unibl.org/sr-lat/fis/zaposlen/3299-antonija-verhaz</dcterms:creator>
          <dcterms:creator xsi:type="dcterms:URI" title="Татјана Рогановић">https://www.unibl.org/sr-lat/fis/zaposlen/5473-tatjana-roganovic</dcterms:creator>
          <dcterms:creator xsi:type="dcterms:URI" title="Тања Мацановић-Костић">/unibl/author/Tanja Macanović-Kostić</dcterms:creator>
          <dcterms:date>2018-09</dcterms:date>
          <dcterms:type>Conference Paper</dcterms:type>
          <dcterms:type>text</dcterms:type>
          <dcterms:format>5</dcterms:format>
          <dcterms:identifier>/unibl/sci/idNaucniRad:20860</dcterms:identifier>
          <dcterms:relation xsi:type="dcterms:URI" title="Медицински факултет">https://med.unibl.org</dcterms:relation>
          <dcterms:relation xsi:type="dcterms:URI" title="Медицински факултет">https://med.unibl.org</dcterms:relation>
          <dcterms:relation>25. SIMPOZIJA INFEKTOLOGA BiH S MEĐUNARODNIM SUDJELOVANJEM</dcterms:relation>
          <dcterms:bibliographicCitation>A. Verhaz, Т. Рогановић, Т. Мацановић-Костић, EFFICACY AND SAFETY OF OMBITASVIR/PARITAPREVIR/RITONAVIR ± DASABUVIR REGIMEN IN PATIENTS WITH SEVERE RENAL IMPAIRMENT WITH HCV GENOTYPE 1B INFECTION – CASE REPORT, Sep, 2018</dcterms:bibliographicCitation>
          <dcterms:identifier xsi:type="dcterms:URI">https://pub.unibl.org/s/cir/item/24880</dcterms:identifier>
        </oai_dcterms:dcterms>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>